Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Carcinoma, Renal Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma 3Burkitt Lymphoma 3Stomach Neoplasms 2Kidney Neoplasms 2Carcinoma, Ovarian Epithelial 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocytopenia 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1

Interventions

Paclitaxel 6Radiotherapy 5Fluorouracil 5Cisplatin 4Taxes 3Specimen Handling 3Radiation 2Erlotinib Hydrochloride 2Endoscopy, Digestive System 2Endoscopy 2trastuzumab biosimilar HLX02 1rubitecan 1romidepsin 1oblimersen 1obeticholic acid 1cixutumumab 1bryostatin 1 1alvocidib 1adavosertib 1Trastuzumab 1Ramucirumab 1Radiofrequency Ablation 1PF-05280014 1Oxaliplatin 1Ontruzant 1Ogivri 1Nivolumab 1Neoadjuvant Therapy 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenocarcinoma Of Esophagus × bryostatin 1 × Clear all
NCT00005599 2013-06-21

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡